Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Jun 19;284(6332):1822–1825. doi: 10.1136/bmj.284.6332.1822

Purified interferon as protection against rhinovirus infection.

G M Scott, R J Phillpotts, J Wallace, D S Secher, K Cantell, D A Tyrrell
PMCID: PMC1498753  PMID: 6177374

Abstract

In a double-blind placebo-controlled study a preparation of human leucocyte interferon purified by affinity chromatography using a monoclonal antibody and applied by repeated nasal sprays reduced the incidence and severity of colds in volunteers challenged with human rhinovirus 9. Although interferon itself caused some symptoms, these were minor compared with the clinical colds. Interferon activity was still detectable in nasal washings as long as 26 hours after the last dose in about half the volunteers on active treatment.

Full text

PDF
1825

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki F. Y., Crowley J. C. Distribution and removal of human serum albumin-technetium 99m instilled intranasally. Br J Clin Pharmacol. 1976 Oct;3(5):869–878. doi: 10.1111/j.1365-2125.1976.tb00640.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cantell K., Hirvonen S. Large-scale production of human leukocyte interferon containing 10(8) units per ml. J Gen Virol. 1978 Jun;39(3):541–543. doi: 10.1099/0022-1317-39-3-541. [DOI] [PubMed] [Google Scholar]
  3. Denham M. J., Foster A., Tyrrell D. A. Work of a district ethical committee. Br Med J. 1979 Oct 27;2(6197):1042–1045. doi: 10.1136/bmj.2.6197.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greenberg S. B., Harmon M. W., Johnson P. E., Couch R. B. Antiviral activity of intranasally applied human leukocyte interferon. Antimicrob Agents Chemother. 1978 Oct;14(4):596–600. doi: 10.1128/aac.14.4.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Harmon M. W., Greenberg S. B., Johnson P. E., Couch R. B. Human nasal epithelial cell culture system: evaluation of response to human interferons. Infect Immun. 1977 May;16(2):480–485. doi: 10.1128/iai.16.2.480-485.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Johnson P. E., Greenberg S. B., Harmon M. W., Alford B. R., Couch R. B. Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans. J Clin Microbiol. 1976 Jul;4(1):106–107. doi: 10.1128/jcm.4.1.106-107.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  8. Scott G. M., Reed S., Cartwright T., Tyrrell D. Failure of human fibroblast interferon to protect against rhinovirus infection. Arch Virol. 1980;65(2):135–139. doi: 10.1007/BF01317324. [DOI] [PubMed] [Google Scholar]
  9. Scott G. M., Secher D. S., Flowers D., Bate J., Cantell K., Tyrrell D. A. Toxicity of interferon. Br Med J (Clin Res Ed) 1981 Apr 25;282(6273):1345–1348. doi: 10.1136/bmj.282.6273.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Secher D. S., Burke D. C. A monoclonal antibody for large-scale purification of human leukocyte interferon. Nature. 1980 Jun 12;285(5765):446–450. doi: 10.1038/285446a0. [DOI] [PubMed] [Google Scholar]
  11. Secher D. S. Immunoradiometric assay of human leukocyte interferon using monoclonal antibody. Nature. 1981 Apr 9;290(5806):501–503. doi: 10.1038/290501a0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES